NCT04688814

Brief Summary

The study will evaluate ultrasound guided SEQ block: single puncture combined lumbar erector spinae plane block and paraspinous sagittal shift (PSSS) quadratus lumborum block when compared with conventional intravenous morphine analgesia in patients undergoing posterior column acetabular fracture surgery

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Dec 2020

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

December 25, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

March 3, 2022

Status Verified

February 1, 2022

Enrollment Period

1 year

First QC Date

December 21, 2020

Last Update Submit

February 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total postoperative morphine consumption

    Compare the total postoperative opioid (morphine) consumption after posterior column acetabular surgery when providing ultrasound guided SEQ block: single puncture combined lumbar erector spinae plane block and paraspinous sagittal shift (PSSS) quadratus lumborum block versus conventional intravenous morphine analgesia. Morphine 0.05 mg/kg will be given intravenously when VAS score is ≥ 4. The total postoperative morphine consumption in milligrams will be recorded.

    24 hours postoperatively

Secondary Outcomes (4)

  • Heart rate (HR)

    24 hours

  • Mean arterial blood pressure (MABP)

    24 hours

  • Resting and dynamic visual analogue score

    24 hours

  • Postoperative complications

    24 hours

Study Arms (2)

Morphine Group

ACTIVE COMPARATOR

Patients will receive GA and analgesia will be based on opioids mainly intravenous morphine. Intravenous morphine in a dose of 0.05 mg/kg will be given as a rescue analgesic when the VAS ≥4 postoperatively for 24 hours

Drug: Morphine Sulfate

SEQ group

EXPERIMENTAL

Patients will receive ultrasound guided SEQ block preoperatively before the induction of general anaesthesia. Twenty five ml of 0.25 % bupivacaine will be given in the QL plane and 25 ml of the same concentration will be given in the erector spine plane

Procedure: Single puncture combined lumbar erector spinae plane block and quadrates lumborum block

Interventions

Patients will lay laterally with the fracture side independent, a curvilinear transducer will be placed in a parasagittal plane 3-4 cm lateral to the lumbar spinous process of L4.The probe is shifted slowly to the lateral side till the transverse processes disappear. After subcutaneous local infiltration with lidocaine 1% at the cephalic end of the probe, the block needle is advanced through the erector spinae and QL muscles, until it pierces the epimysium of the QL muscle. LA is injected anterior to the QL, between the QL and psoas muscles. Then the caudal end of the probe is rotated slowly medially towards lumbar spine till the transverse process of L4 appears in the ultrasound image. The needle is withdrawn to subcutaneous tissue, then advanced in plane towards transverse process of L4. After contacting it, LA is deposited between transverse process and overlying ESM.

Also known as: SEQ group
SEQ group

Patients will receive GA and analgesia will be based on opioids mainly intravenous morphine

Also known as: MOR group
Morphine Group

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I-III patients
  • Unilateral posterior wall/column acetabular fractures surgery using posterior approach

You may not qualify if:

  • BMI \> 35 kg/m2
  • Pre-existing neurological deficit
  • Spine deformity
  • Pregnancy/lactation
  • Significant renal impairment
  • Significant Hepatic impairment
  • Known contraindications to peripheral nerve block (coagulopathy or infection at the site of injection)
  • Chronic opioid users/abusers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alexandria Faculty of Medicine

Alexandria, 21651, Egypt

Location

Related Publications (1)

  • Chelly JE, Casati A, Al-Samsam T, Coupe K, Criswell A, Tucker J. Continuous lumbar plexus block for acute postoperative pain management after open reduction and internal fixation of acetabular fractures. J Orthop Trauma. 2003 May;17(5):362-7. doi: 10.1097/00005131-200305000-00007.

    PMID: 12759641BACKGROUND

MeSH Terms

Conditions

NeuralgiaPain, Postoperative

Interventions

Morphine

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic Processes

Intervention Hierarchy (Ancestors)

Morphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Moustafa A Moustafa, Professor

    Alexandria Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Double blinded
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anaesthesia and Surgical Intensive Care

Study Record Dates

First Submitted

December 21, 2020

First Posted

December 30, 2020

Study Start

December 25, 2020

Primary Completion

December 25, 2021

Study Completion

February 15, 2022

Last Updated

March 3, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will share

Data will be shared on request

Shared Documents
STUDY PROTOCOL
Time Frame
Data will become available after 1 year for one year
Access Criteria
Via mail of the principal investigator

Available IPD Datasets

Study Protocol Access

Locations